Thermo Fisher Scientific Stock Börse Stuttgart

Equities

TN8

US8835561023

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 11:38:48 2024-07-17 am EDT 5-day change 1st Jan Change
507.2 EUR -0.29% Intraday chart for Thermo Fisher Scientific +2.86% +5.98%
Sales 2024 * 43B 39.33B Sales 2025 * 45.98B 42.05B Capitalization 212B 194B
Net income 2024 * 6.18B 5.65B Net income 2025 * 6.94B 6.35B EV / Sales 2024 * 5.47 x
Net Debt 2024 * 23.2B 21.22B Net Debt 2025 * 19.14B 17.5B EV / Sales 2025 * 5.03 x
P/E ratio 2024 *
34.7 x
P/E ratio 2025 *
29.9 x
Employees -
Yield 2024 *
0.27%
Yield 2025 *
0.29%
Free-Float 86.04%
More Fundamentals * Assessed data
Dynamic Chart
Orthofix Names Stephanie Walsh as Chief Human Resources Officer CI
Thermo Fisher Scientific Keeps Quarterly Cash Dividend at $0.39 Per Share, Payable Oct. 15 to Holders as of Sept. 13 MT
Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on October 15, 2024 CI
Thermo Fisher Scientific to Work With National Cancer Institute to Advance Research on New Treatments MT
Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology CI
Thermo Fisher Scientific Completes Acquisition of Olink MT
Thermo Fisher Scientific Inc. completed the acquisition of Olink Holding AB from Summa Equity AB and others. CI
Thermo Fisher Scientific Opens Its First Electron Microscopy Demo Center in Taiwan CI
Olink Holding Receives UK Approval for Thermo Fisher's $26 per Share Tender Offer MT
UK Competition Watchdog Clears Thermo Fisher Scientific's Purchase of Sweden's Olink MT
UK's competition regulator clears $3.1 billion Thermo Fisher Scientific-Olink deal RE
Evercore ISI Cuts Price Target on Thermo Fisher Scientific to $600 From $615, Maintains Outperform Rating MT
Verici Dx hails milestone payment in deal with Thermo Fisher AN
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell Top 200 Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 3000 Growth Index CI
More news
1 week+2.86%
Current month-0.31%
1 month-4.63%
3 months-2.49%
6 months+1.72%
Current year+5.98%
More quotes
1 week
489.50
Extreme 489.5
508.60
1 month
489.50
Extreme 489.5
532.70
3 years
393.90
Extreme 393.9
598.20
5 years
234.85
Extreme 234.85
598.20
10 years
84.56
Extreme 84.56
598.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01-10-31
Director of Finance/CFO 57 01-05-31
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Chief Executive Officer 56 01-10-31
Director/Board Member 67 12-03-29
Director/Board Member 62 22-02-28
More insiders
Date Price Change
24-07-17 503.5 -1.00%
24-07-16 508.6 +1.74%
24-07-15 499.9 -0.71%
24-07-12 503.5 +0.79%
24-07-11 499.6 +1.40%

Delayed Quote Börse Stuttgart, July 17, 2024 at 09:00 am EDT

More quotes
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
555.4 USD
Average target price
628.2 USD
Spread / Average Target
+13.10%
Consensus